| Item Type | Name |
|
Concept
|
Prognosis
|
|
Academic Article
|
Locoregional MYCN-amplified neuroblastoma.
|
|
Academic Article
|
Changes over three decades in outcome and the prognostic influence of age-at-diagnosis in young patients with neuroblastoma: a report from the International Neuroblastoma Risk Group Project.
|
|
Academic Article
|
Peripheral neuroblastic tumors with genotype-phenotype discordance: a report from the Children's Oncology Group and the International Neuroblastoma Pathology Committee.
|
|
Academic Article
|
Prognostic value of the stage 4S metastatic pattern and tumor biology in patients with metastatic neuroblastoma diagnosed between birth and 18 months of age.
|
|
Academic Article
|
Semiquantitative mIBG scoring as a prognostic indicator in patients with stage 4 neuroblastoma: a report from the Children's oncology group.
|
|
Academic Article
|
Clinical and biologic features predictive of survival after relapse of neuroblastoma: a report from the International Neuroblastoma Risk Group project.
|
|
Academic Article
|
ABCC multidrug transporters in childhood neuroblastoma: clinical and biological effects independent of cytotoxic drug efflux.
|
|
Academic Article
|
Metastatic neuroblastoma confined to distant lymph nodes (stage 4N) predicts outcome in patients with stage 4 disease: A study from the International Neuroblastoma Risk Group Database.
|
|
Academic Article
|
Clinical, biologic, and prognostic differences on the basis of primary tumor site in neuroblastoma: a report from the international neuroblastoma risk group project.
|
|
Academic Article
|
Second malignancies in patients with neuroblastoma: the effects of risk-based therapy.
|
|
Academic Article
|
Neuroblastoma of undifferentiated subtype, prognostic significance of prominent nucleolar formation, and MYC/MYCN protein expression: a report from the Children's Oncology Group.
|
|
Academic Article
|
Neuroblastoma in older children, adolescents and young adults: a report from the International Neuroblastoma Risk Group project.
|
|
Academic Article
|
Validation of a prognostic multi-gene signature in high-risk neuroblastoma using the high throughput digital NanoString nCounter™ system.
|
|
Academic Article
|
Treatment of two cases with refractory, metastatic intermediate-risk neuroblastoma with isotretenoin alone or observation.
|
|
Academic Article
|
Prognostic significance of pattern and burden of metastatic disease in patients with stage 4 neuroblastoma: A study from the International Neuroblastoma Risk Group database.
|
|
Academic Article
|
Integrative genomics reveals hypoxia inducible genes that are associated with a poor prognosis in neuroblastoma patients.
|
|
Academic Article
|
Augmented expression of MYC and/or MYCN protein defines highly aggressive MYC-driven neuroblastoma: a Children's Oncology Group study.
|
|
Grant
|
The Role of SPARC in Neuroblastoma Angiogenesis
|
|
Academic Article
|
Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project.
|
|
Academic Article
|
Statistical Framework in Support of a Revised Children's Oncology Group Neuroblastoma Risk Classification System.
|
|
Academic Article
|
Unrealistic parental expectations for cure in poor-prognosis childhood cancer.
|
|
Academic Article
|
Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1-2 trial.
|
|
Academic Article
|
5-Hydroxymethylcytosine Profiles in Circulating Cell-Free DNA Associate with Disease Burden in Children with Neuroblastoma.
|
|
Academic Article
|
Age, Diagnostic Category, Tumor Grade, and Mitosis-Karyorrhexis Index Are Independently Prognostic in Neuroblastoma: An INRG Project.
|
|
Academic Article
|
The prognostic strength of serum LDH and serum ferritin in children with neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project.
|
|
Academic Article
|
Association between end-induction response according to the revised International Neuroblastoma Response Criteria (INRC) and outcome in high-risk neuroblastoma patients.
|
|
Academic Article
|
Reply to K. Beiske et al.
|
|
Academic Article
|
A nomogram of clinical and biologic factors to predict survival in children newly diagnosed with high-risk neuroblastoma: An International Neuroblastoma Risk Group project.
|
|
Academic Article
|
Stage 4S Neuroblastoma: Molecular, Histologic, and Immunohistochemical Characteristics and Presence of 2 Distinct Patterns of MYCN Protein Overexpression-A Report From the Children's Oncology Group.
|
|
Academic Article
|
Immunogenomic determinants of tumor microenvironment correlate with superior survival in high-risk neuroblastoma.
|
|
Academic Article
|
Randomized Phase II Trial of MIBG Versus MIBG, Vincristine, and Irinotecan Versus MIBG and Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A Report From NANT Consortium.
|
|
Academic Article
|
Age Dependency of the Prognostic Impact of Tumor Genomics in Localized Resectable MYCN-Nonamplified Neuroblastomas. Report From the SIOPEN Biology Group on the LNESG Trials and a COG Validation Group.
|
|
Academic Article
|
Efficacy of post-induction therapy for high-risk neuroblastoma patients with end-induction residual disease.
|
|
Academic Article
|
Survival of Patients With Neuroblastoma After Assignment to Reduced Therapy Because of the 12- to 18-Month Change in Age Cutoff in Children's Oncology Group Risk Stratification.
|
|
Academic Article
|
Adrenergic and mesenchymal signatures are identifiable in cell-free DNA and correlate with metastatic disease burden in children with neuroblastoma.
|
|
Academic Article
|
Long-term follow-up of patients with intermediate-risk neuroblastoma treated with response- and biology-based therapy: A report from the Children's Oncology Group study ANBL0531.
|
|
Academic Article
|
Characterizing Relationships between T-cell Inflammation and Outcomes in Patients with High-Risk Neuroblastoma According to Mesenchymal and Adrenergic Signatures.
|